EN
HI
Kabra Drugs Chart
Kabra Drugs Share Key Metrics
Volume
52304.00
Market Cap
59.39 CR
LTQ@LTP
1@25.00
ATP
25.16
Var Margin
25 %
Circuit Range
22.55-27.55
Delivery %
83.34 %
Value
13.16 L
ASM/GSM
No
Market Lot
1
Summary
Kabra Drugs share price stands at ₹25 at 24 Apr, 2026 | 15:29. The stock Kabra Drugs intraday movement has stayed between ₹24.90 and ₹25.70, while on a 52-week basis it has fluctuated from ₹10.56 to ₹35.52.
In terms of trading activity, Kabra Drugs has recorded a volume of 52304 shares. The Kabra Drugs has a market cap of ₹23707850. The stock’s Average Traded Price (ATP) stands at ₹2516, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 2500.
The Kabra Drugs operates within a circuit range of ₹22.55-27.55 – ₹22.55-27.55, with a Value of ₹13.16 L. The Delivery Percentage for the day is 83.34%. Additionally, Kabra Drugs currently falls under the No framework, and trades with a market lot size of 1.
Kabra Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
63.82
Sector P/B
3.5
Sec. Div. Yield
0.57
Kabra Drugs Resistance and Support
Pivot 25.48
Resistance
First Resistance
26.46
Second Resistance
27.87
Third Resistance
28.85
Support
First Support
24.07
Second Support
23.09
Third Support
21.68
Kabra Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-04-21 | Others |
| 2026-03-07 | Others |
| 2026-02-13 | Quarterly Results |
| 2025-11-28 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-10-08 | Others |
| 2025-09-02 | Others |
| 2025-08-14 | Quarterly Results |
| 2025-08-06 | Others |
| 2025-06-18 | Others |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
Kabra Drugs News
Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Change in Directorate
Kabra Drugs Limited appointed Ms. Monam Kapoor as an Additional Director, designated as Non-Executive and Independent Director, effective April 21, 2026. This appointment is for a period of 5 years, subject to shareholder approval.
Apr 21 2026 18:04:00
Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 21-April-2026
Kabra Drugs Limited's board will convene on April 21, 2026, to consider appointment of Ms. Monam Kapoor as an Additional Director and major diversification plans. The company aims to expand into drone & defense equipment, AI technologies, e-pharmacy, dairy products, hospitality, and agro-based businesses.
Apr 10 2026 14:04:00
About Kabra Drugs
NSE : 0
BSE : 524322
ISIN : INE323K01017
Kabra Drugs Management
| Name | Position |
|---|---|
| N Aravind | Managing Director |
| Kuniamuthur Nanjappan Anand | Executive Director |
Kabra Drugs Similar Stocks
Broach Lifecare Hospital Ltd.
16.00
0.00 (0.00%)
Starsource Multitrade Ltd.
110.00
0.00 (0.00%)
Unjha Formulations Ltd.
20.97
-0.38 (1.78%)
Ortin Global Ltd.
14.50
0.00 (0.00%)
Hindustan Bio Sciences Ltd.
9.45
0.19 (2.05%)
Dhanvantri Jeevan Rekha Ltd.
26.32
0.00 (0.00%)
Dolphin Medical Services Ltd.
5.63
0.00 (0.00%)
Dr Lalchandani Labs Ltd.
9.61
0.00 (0.00%)
Decipher Labs Ltd.
7.85
-0.02 (0.25%)
Kabra Drugs FAQs
The Buying Price of Kabra Drugs share is 25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kabra Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kabra Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 63.82 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kabra Drugs is 59.39 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kabra Drugs share price is 35.52 & 10.56. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kabra Drugs belongs to the Healthcare sector.
